Previous 10 | Next 10 |
2024-03-07 09:41:59 ET More on ImmunoPrecise ImmunoPrecise Antibodies Ltd. (IPA) Q2 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on ImmunoPrecise Historical earnings data for ImmunoPrecise Financial information for ImmunoPrecise ...
2024-03-07 09:09:27 ET CERo Therapeutics ( CERO ) +625% after announces publication of preclinical research supporting the use of its clinical candidate CER-1236 to treat AML patients . Lytus Technologies ( LYT ) +210% after enters $326 billion data center market...
2024-03-07 08:33:11 ET DENVER, Colo., Mar 07, 2024 ( 247marketnews.com )- IPA (NASDAQ: IPA ) reported, this morning, the development of a Foundation AI Model, which combines the strengths of Large Language Models (LLMs) through an advanced stacking technique with BioStrand’s ...
Dirk Van Hyfte MD, PhD, Co-Founder and Head of Innovation of BioStrand, to present findings live next week at the HIMSS24 conference in Orlando, Florida IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-dri...
The Company to host an earnings conference call via webcast. IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today announced that it will host a conf...
VICTORIA, BC / ACCESSWIRE / February 13, 2024 / Even though we speak, listen, read and write every day, language is incredibly complex and ever-evolving. Context is critical to understanding. In the English language, there are a plethora of words that are spelled the same but have vastly differe...
2024-02-05 13:05:53 ET More on Mid-day movers $ stocks. Karyopharm: Approaching The Bottom Ahead Of Earnings And Topline Data (Rating Upgrade) Karyopharm Therapeutics: Promising Potential With 3 Ongoing Phase 3 Studies But Risky Peraso Inc. (PRSO) Q3 2023 Earnings Ca...
VICTORIA, BC / ACCESSWIRE / January 10, 2024 / ImmunoPrecise Antibodies (NASDAQ:IPA) ("IPA"), a leading company in AI-driven biotherapeutic research and technology, has recently provided an update to investors as it reported earnings for Q2 FY2024. The company is known for its pioneering wor...
2023-12-14 13:51:23 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips ImmunoPrecise Antibodies (NASDAQ: IPA ) just reported results for the second quarter of 2024. ImmunoPrecise Antibodies reported earnings per share of -7.4 cents. This was ...
2023-12-14 12:49:18 ET More on ImmunoPrecise ImmunoPrecise Antibodies Ltd. (IPA) Q2 2024 Earnings Call Transcript ImmunoPrecise Antibodies appoints Mitch Levine as Chairman of Board Seeking Alpha’s Quant Rating on ImmunoPrecise Historical earnings data...
News, Short Squeeze, Breakout and More Instantly...
ImmunoPrecise Antibodies Ltd. Company Name:
IPA Stock Symbol:
NASDAQ Market:
ImmunoPrecise Antibodies Ltd. Website:
The Company to host an earnings conference call via webcast ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA) today announces the rescheduling of its full year fiscal 2024 financial results and business highlights release. Originally set for July 25, 2024, the new rel...
ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced that it has entered into a securities purchase agreement (the “Securities Purchase Agreement”) with YA II ...
The Company to host an earnings conference call via webcast IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, will announce its full year fiscal 2024 financial results and ...